Table 2.
n | Number (%) of transitions to injecting |
Person-years at risk |
Incidence per 100 PYAR |
95% CI | HRa | 95% CI | Adjusted HRa | 95% CI | |
---|---|---|---|---|---|---|---|---|---|
All | 266 | 63 (24) | 282 | 22.3 | 17.2–28.2 | na | na | na | na |
Injection history | |||||||||
Never injectors | 219 | 43 (20) | 232.5 | 18.5 | 13.4–24.4 | 1.0 | na | 1.0 | na |
Former injectors | 47 | 20 (43) | 49.5 | 40.4 | 24.6–60.0 | 1.93* | 1.12–3.34 | 2.26** | 1.19–4.29 |
Adjusted for age, ever in drug treatment, HBV infected at baseline, years since starting heroin use and always used heroin intra-nasally in past 30 days.
p < 0.05.
p < 0.01.